| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $57.8M | -67.2% |
| R&D Expense | $111.5M | -52.4% |
| SG&A Expense | $44.7M | -26.9% |
| Operating Income | -$104.0M | +62.1% |
| Pre-tax Income | -$98.1M | +62.7% |
| Income Tax | -$167K | +96.7% |
| Net Income | -$97.9M | +62.0% |
| EPS (Basic) | -$0.49 | +66.9% |
| EPS (Diluted) | -$0.49 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $41.9M | -7.3% |
| Accounts Receivable | $526K | -43.0% |
| Current Assets | $51.7M | -45.2% |
| Total Assets | $101.6M | -38.5% |
| Current Liabilities | $45.8M | -4.0% |
| Total Liabilities | $78.9M | -4.3% |
| Stockholders' Equity | $22.8M | -72.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$67.1M | +70.1% |
| Capital Expenditures | $267K | -98.7% |
| Investing Cash Flow | $37.5M | -75.6% |
| Financing Cash Flow | $28.4M | +94.5% |
| Free Cash Flow | -$67.4M | +72.6% |
| +66.9% |